Searchable abstracts of presentations at key conferences in endocrinology

ea0051p017 | Gonadal, DSD and reproduction | BSPED2017

Turner syndrome transition - audit of paediatric clinic, RHC Glasgow

Abbas Joshua , Mason Avril

Background: Turner syndrome is a lifelong condition that requires lifelong engagement with health services. The Paediatric Endocrinologist has a role in developing a plan for transition and establishing follow-up in an adult clinic. A clinic proforma outlining expected investigations during transition has been in use in the Glasgow Turner clinic since 2015 based on the recommendations of the Turner Syndrome Study Group. More recently The Endocrine Society Transition Toolkit ha...

ea0051p028 | Miscellaneous/other | BSPED2017

Introducing a patient held record in a turner transition clinic, RHC Glasgow

McBride Teresa , Mason Avril

Introduction: A Patient Held Record (PHR) has been developed for use in adolescent girls with Turner Syndrome (TS) attending a dedicated Turner Transition clinic, RHC Glasgow. The PHR has been devised to encourage knowledge of TS; medcial care and ways to maintain good health and to promote self advocacy.Aim: To assess patient acceptability and user friendliness of a PHR in adolescent girls with TS.Method: A PHR and questionnaire w...

ea0059p073 | Clinical practice, governance & case reports | SFEBES2018

Transition in Turner syndrome

Zahra Baryab , Mason Avril

Background: A Turner Syndrome (TS) Transition clinic, Royal Hospital for Children Glasgow(RHCG), with paediatric and adult endocrinology/gynaecology teams was set up in 1998.Objective: 1) To evaluate the success of TS transition2) To determine what factors influence long-term follow-up in an adult service – good early attendance in an adult clinic and meeting an adult specialist prior to transfer to adult clinic.<p class="...

ea0085oc10.1 | Oral Communications 10 | BSPED2022

Hormone replacement therapy in paediatric turner syndrome – evaluation of current practice in a dedicated paediatric turner clinic and subsequent development of patient resources

Mackie Gabriella , Smyth Arlene , Mason Avril

The British Society for Paediatric Endocrine and Diabetes (BSPED) published guidance in 2016 on optimal Hormonal Replacement Therapy (HRT) for pubertal induction in Turner Syndrome (TS). Transdermal preparations of oestrogen are the most appropriate method of oestrogen delivery in TS, as it avoids first pass metabolism of the liver, and thereby does not exert a meaningful effect on blood pressure.Objective: To assess change in prescribing practice in acc...

ea0085p33 | Miscellaneous 1 | BSPED2022

Cardiac imaging in a dedicated paediatric turner syndrome clinic

Carr Aoife , Hunter Lindsey , Mason Avril

Background: Turner Syndrome (TS) is a complete or partial loss of the second X chromosome affecting approximately 1:2000 females, classically associated with short stature and hypogonadism. Cardiovascular complications in TS include increased risk of congenital cardiac malformations, hypertension, ischaemic heart disease and aortic dissection. Cardiovascular related deaths account for over 40% of the excess mortality in TS and requires lifelong monitoring and follow-up. The Cl...

ea0085p72 | Miscellaneous 2 | BSPED2022

Evaluation of an educational intervention on puberty/pubertal induction in adolescent girls with turner syndrome

Mackie Gabriella , Smyth Arlene , Mason Avril

In 2019, we attended a patient engagement zoom session, hosted by Turner Syndrome Support Society (TSSS), to launch a video illustrating the use of a transdermal patch for pubertal induction in girls with Turner Syndrome (TS). Several girls raised to us that they felt that they did not have a good understanding of puberty, and on why it was important to receive both oestrogen and progesterone preparations during pubertal induction. To target this, we developed an explanatory v...

ea0085p23 | Gonadal, DSD and Reproduction | BSPED2022

The prevalence of hypertension in children and adolescents with turner syndrome: a systematic review and meta-analysis

McCarrison Sarah , Carr Aoife , Choong Wong Sze , Mason Avril

Background: Cardiovascular related deaths account for over 40% of the excess mortality in Turner Syndrome (TS). Hypertension, a modifiable risk factor for both aortic dilatation and dissection, is more commonly encountered in TS during childhood and adolescence. The objective of this systematic review and meta-analysis is to determine the prevalence of hypertension in paediatric patients with TS and in relation to the methodologies of blood pressure evaluation.<p class="ab...

ea0039oc9.3 | Oral Communications 9 | BSPED2015

National audit of transition in endocrinology: joint between society for endocrinology and the british society for paediatric endocrinology & diabetes

Gleeson Helena , Mason Avril , Shaikh Guftar , Dimitri Paul

Background: Transition is an important stage in the care of a young person with a long-term endocrine condition.Objective: To explore current services for young people (YP) with endocrine conditions from the perspective of paediatric and adult endocrinologists, and YP and their parents using their services.Methods: There were two components:- i). service questionnaire for completion by paediatric and adult endocrinologists ii). &#1...

ea0045p43 | Gonadal, DSD and reproduction | BSPED2016

Extending the clinical utility of urinary gonadotrophin estimation in turner syndrome

McNeilly Jane D , Ahmed S Faisal , Mason Avril

Background: Girls with Turner Syndrome (TS) are at increased risk of primary ovarian failure. Previous studies have demonstrated that urinary gonadotrophins (UG) can be used as a non- invasive biochemical marker of pubertal status but their value in monitoring and managing girls with primary ovarian failure is unclear.Aims: To determine the range of UG in girls with Turner Syndrome (TS) and its correlation to serum LH and FSH.Patie...

ea0095oc10.6 | Oral Communications 10 | BSPED2023

An appraisal on the quality and readability of growth hormone therapy patient information developed by paediatric endocrine societies

McKechnie Jennifer , Qian Ho Zhe , Mason Avril , Wong Sze Choon

Background: In the UK, recombinant human growth hormone(rhGH) is approved for children with growth failure associated with six different conditions. According to NICE guidelines, clinicians should have a comprehensive discussion with patients and/or caregivers about treatment options. Research shows that patients retain only about 20% of the information provided during a consultation. This can be improved to around 50% when written information is also provided...